// April 17, 2023
USP’s Preferential Access for Regulators (PAR) Program: Supporting the Global Supply of Quality Medicines
In the U.S. and around the world, quality standards developed by the U.S.
In the U.S. and around the world, quality standards developed by the U.S.
Quality should be built into the entire drug product lifecycle – including the manufacturing and
As the impact of the COVID-19 pandemic continues to unfold, each day brings to light